{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:12:05Z","timestamp":1748059925222,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"DOI":"10.7759\/cureus.84680","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:20:19Z","timestamp":1748017219000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hypercalcemia in Burkitt Lymphoma Following Heart Transplant in an Elderly Male"],"prefix":"10.7759","author":[{"given":"Alyssa","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani K","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Banjade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Kacarow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabin","family":"Tripathee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26001","article-title":"Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder","volume":"117","author":"Picarsic J","year":"2011","unstructured":"Picarsic J, Jaffe R, Mazariegos G, Webber SA, Ellis D, Green MD, Reyes-M\u00fagica M. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Cancer. 2011, 117:4540-50. 10.1002\/cncr.26001","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/07357900009012197","article-title":"Burkitt's lymphoma: molecular pathogenesis and treatment","volume":"18","author":"Bishop PC","year":"2000","unstructured":"Bishop PC, Rao VK, Wilson WH. Burkitt's lymphoma: molecular pathogenesis and treatment. Cancer Invest. 2000, 18:574-83. 10.3109\/07357900009012197","journal-title":"Cancer Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27482","article-title":"Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients","volume":"118","author":"Zimmermann H","year":"2012","unstructured":"Zimmermann H, Reinke P, Neuhaus R, et al.. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients. Cancer. 2012, 118:4715-24. 10.1002\/cncr.27482","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka V","year":"2016","unstructured":"Dharnidharka V, Webster A, Martinez O. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016, 2:15088.","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1702693","article-title":"Post-transplantation lymphoproliferative disorders in adults","volume":"378","author":"Dierickx D","year":"2018","unstructured":"Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018, 378:549-62. 10.1056\/NEJMra1702693","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-013-0162-5","article-title":"Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies","volume":"8","author":"Al-Mansour Z","year":"2013","unstructured":"Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013, 8:173-83. 10.1007\/s11899-013-0162-5","journal-title":"Curr Hematol Malig Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.88","article-title":"Post-transplant lymphoproliferative disorders","volume":"2","author":"Dharnidharka VR","year":"2016","unstructured":"Dharnidharka VR, Webster AC, Martinez OM, Preiksaitis JK, Leblond V, Choquet S. Post-transplant lymphoproliferative disorders. Nat Rev Dis Primers. 2016, 2:15088. 10.1038\/nrdp.2015.88","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12004","article-title":"Epstein-Barr virus infection and posttransplant lymphoproliferative disorder","volume":"13 Suppl 3","author":"Green M","year":"2013","unstructured":"Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013, 13 Suppl 3:41-54; quiz 54. 10.1111\/ajt.12004","journal-title":"Am J Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt's lymphoma","volume":"31","author":"Molyneux EM","year":"2012","unstructured":"Molyneux EM, Rochford R, Griffin B. Burkitt's lymphoma. Lancet. 2012, 31:1234-44. 10.1016\/S0140-6736(11)61177-X","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz G","year":"2004","unstructured":"Opelz G, D\u00f6hler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004, 4:222-30. 10.1046\/j.1600-6143.2003.00325.x","journal-title":"Am J Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/150835","article-title":"Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?","volume":"2013","author":"Morscio J","year":"2013","unstructured":"Morscio J, Dierickx D, Tousseyn T. Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?. Clin Dev Immunol. 2013, 2013:150835. 10.1155\/2013\/150835","journal-title":"Clin Dev Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2005.00342.x","article-title":"Early onset post-transplant lymphoproliferative disease is associated with allograft localization","volume":"19","author":"Bakker NA","year":"2005","unstructured":"Bakker NA, van Imhoff GW, Verschuuren EA, et al.. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant. 2005, 19:327-34. 10.1111\/j.1399-0012.2005.00342.x","journal-title":"Clin Transplant"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit391","article-title":"Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases working party of the Europea","volume":"57","author":"Styczynski J","year":"2013","unstructured":"Styczynski J, Gil L, Tridello G, et al.. Response to rituximab-based therapy and risk factor analysis in Epstein Barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases working party of the Europea. Clin Infect Dis. 2013, 57:794-802. 10.1093\/cid\/cit391","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt's lymphoma","volume":"369","author":"Dunleavy K","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Shovlin M, et al.. Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med. 2013, 369:1915-25. 10.1056\/NEJMoa1308392","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Trappe R","year":"2012","unstructured":"Trappe R, Oertel S, Leblond V. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol. 2012, 13:196-206. 10.1016\/S1470-2045(11)70300-X","journal-title":"Lancet Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2006.02.001","article-title":"CNS prophylaxis in lymphoma: who to target and what therapy to use","volume":"20","author":"Hill QA","year":"2006","unstructured":"Hill QA, Owen RG. CNS prophylaxis in lymphoma: who to target and what therapy to use. Blood Rev. 2006, 20:319-32. 10.1016\/j.blre.2006.02.001","journal-title":"Blood Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"Ghobrial IM","year":"2005","unstructured":"Ghobrial IM, Habermann TM, Maurer MJ, et al.. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol. 2005, 23:7574-82. 10.1200\/JCO.2005.01.0934","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000420)90:2%3C104::AID-IJC6%3E3.0.CO;2-0","article-title":"Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation","volume":"90","author":"Koffman BH","year":"2000","unstructured":"Koffman BH, Kennedy AS, Heyman M. Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation. Int J Cancer. 2000, 90:2-104. 10.1002\/(SICI)1097-0215(20000420)90:2%3C104::AID-IJC6%3E3.0.CO;2-0","journal-title":"Int J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/368340-severe-hypercalcemia-in-burkitt-lymphoma-following-heart-transplant-in-an-elderly-male","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:20:20Z","timestamp":1748017220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/368340-severe-hypercalcemia-in-burkitt-lymphoma-following-heart-transplant-in-an-elderly-male"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84680","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}